Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

NCT02947334 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Primary Hyperlipidemia or Mixed Dyslipidemia

Interventions

BIOLOGICAL: Bococizumab
DRUG: Placebo

Sponsor

Pfizer